KVUE
Kenvue Inc.
Price Chart
Latest Quote
$18.70
-0.06 (-0.32%)
Current Price
| Previous Close | $18.76 |
| Open | $18.67 |
| Day High | $19.02 |
| Day Low | $18.58 |
| Volume | 14,012,788 |
Stock Information
| Quarterly Dividend / Yield | $0.83 / 4.36% |
| Shares Outstanding | 1.92B |
| Quarterly Dividend Yield | 4.36% |
| Quarterly Dividend | $0.83 |
| Total Debt | $8.80B |
| Cash Equivalents | $1.08B |
| Revenue | $15.29B |
| Net Income | $1.62B |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Market Cap | $36.44B |
| P/E Ratio | 22.60 |
| EPS (TTM) | $0.84 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $44.17B |
| Sales | $15.29B |
| Income | $1.62B |
| Book/sh | $5.53 |
| Cash/sh | $0.56 |
| Employees | 22K |
Financial Ratios
| Quick Ratio | 0.61 |
| Current Ratio | 0.98 |
| Debt/Eq | 82.97 |
| EPS Growth TTM | 47.20% |
Returns & Margins
| ROA | 7.07% |
| ROE | 15.70% |
| Gross Margin | 58.60% |
| Operating Margin | 21.62% |
| Profit Margin | 10.61% |
Ownership
| Insider Ownership | 0.05% |
| Institutional Ownership | 95.05% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 15.31 |
| PEG | 1.55 |
| P/S | 2.38 |
| P/B | 3.44 |
Analyst Data
| Recommendation | hold |
| Target Price | $19.75 |
Technical Indicators
| SMA20 | $19.03 |
| SMA50 | $18.12 |
| SMA200 | $17.09 |
| RSI | 47.76 |
| ATR | 0.4686 |
| Shares Float | 1.92B |
| Short Float | 3.54% |
| Short Ratio | 2.64 |
| Volatility | 0.44 |
| Rel Volume | 1.30 |
Performance History
| Week | -2.57% |
| Month | +2.98% |
| Quarter | +10.02% |
| 6 Months | +13.49% |
| YTD | +12.18% |
| Year | -9.10% |
| 3 Years | -15.07% |
| 10 Years | -20.28% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $18.98 | 29,311,200 |
| 2026-07-16 | $19.02 | 15,950,700 |
| 2026-07-15 | $18.70 | 18,492,300 |
| 2026-07-14 | $18.76 | 19,473,900 |
| 2026-07-13 | $19.23 | 39,874,000 |
| 2026-07-10 | $19.48 | 9,451,500 |
| 2026-07-09 | $19.18 | 14,446,500 |
| 2026-07-08 | $19.29 | 12,756,300 |
| 2026-07-07 | $19.78 | 16,317,400 |
| 2026-07-06 | $19.56 | 25,159,300 |
| 2026-07-02 | $19.83 | 11,433,400 |
| 2026-07-01 | $19.33 | 18,773,300 |
| 2026-06-30 | $19.11 | 18,676,000 |
| 2026-06-29 | $19.07 | 21,640,800 |
| 2026-06-26 | $19.13 | 31,070,900 |
| 2026-06-25 | $18.96 | 28,947,600 |
| 2026-06-24 | $18.80 | 46,078,600 |
| 2026-06-23 | $18.41 | 13,460,100 |
| 2026-06-22 | $17.86 | 27,923,300 |
| 2026-06-18 | $18.12 | 32,083,800 |
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
đ° Latest News
VOYA Stock Hits Record High, Tops $100 For The First Time Ever â Report Says Voya Financial Has Been âFieldingâ Takeover Interest
Stocktwits âĸ 2026-07-16T15:01:12Z
4 Dividend Kings Are Crushing the S&P 500 in 2026 and Still Have Big Upside Potential
24/7 Wall St. âĸ 2026-07-14T12:20:03Z
Sector Update: Healthcare Stocks Advance Late Afternoon
MT Newswires âĸ 2026-07-13T19:34:41ZKVUE Stock Dips After Court Revives Tylenol Autism Lawsuits
Stocktwits âĸ 2026-07-13T17:09:55Z
Top Midday Stories: Trump Says US to Be Guardian of Hormuz Strait; Meta to Invest Over $50 Billion in Louisiana Data Center Expansion
MT Newswires âĸ 2026-07-13T15:55:13ZTylenol-Maker Kenvue Must Face Autism Claims, Appeals Court Says
Bloomberg âĸ 2026-07-13T15:20:06Z3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now
24/7 Wall St. âĸ 2026-07-07T17:19:51Z
Kenvue (KVUE) Stock May Be A Bargain Despite The Acquisition Bid
Simply Wall St. âĸ 2026-07-02T22:12:23Z
5 Underperforming Dividend Kings Offer Big Passive Income and Huge Total Return Potential
24/7 Wall St. âĸ 2026-07-02T12:18:39Z
Kenvue (KVUE) Faces A $48.7 Billion Kimberly Clark Deal And Big Portfolio Questions
Simply Wall St. âĸ 2026-07-02T02:12:19Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,332,000,000 | $6,496,000,000 | $6,801,000,000 | $6,665,000,000 |
| Cost Of Revenue | $6,332,000,000 | $6,496,000,000 | $6,801,000,000 | $6,665,000,000 |
| Total Revenue | $15,124,000,000 | $15,455,000,000 | $15,444,000,000 | $14,950,000,000 |
| Operating Revenue | $15,124,000,000 | $15,455,000,000 | $15,444,000,000 | $14,950,000,000 |
| Expenses | ||||
| Interest Expense | $430,000,000 | $431,000,000 | $358,000,000 | $0 |
| Total Expenses | $12,409,000,000 | $12,826,000,000 | $12,951,000,000 | $12,262,000,000 |
| Other Income Expense | $-337,000,000 | $-836,000,000 | $-53,000,000 | $-51,000,000 |
| Other Non Operating Income Expenses | $10,000,000 | $4,000,000 | $-7,000,000 | $3,000,000 |
| Net Non Operating Interest Income Expense | $-379,000,000 | $-378,000,000 | $-250,000,000 | $0 |
| Interest Expense Non Operating | $430,000,000 | $431,000,000 | $358,000,000 | $0 |
| Operating Expense | $6,077,000,000 | $6,330,000,000 | $6,150,000,000 | $5,597,000,000 |
| Other Operating Expenses | $-11,000,000 | $22,000,000 | $9,000,000 | $-36,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,470,000,000 | $1,030,000,000 | $1,664,000,000 | $2,064,000,000 |
| Net Interest Income | $-379,000,000 | $-378,000,000 | $-250,000,000 | $0 |
| Interest Income | $51,000,000 | $53,000,000 | $108,000,000 | $0 |
| Normalized Income | $1,725,172,586 | $1,641,448,763 | $1,698,960,000 | $2,106,282,000 |
| Net Income From Continuing And Discontinued Operation | $1,470,000,000 | $1,030,000,000 | $1,664,000,000 | $2,064,000,000 |
| Total Operating Income As Reported | $2,414,000,000 | $1,841,000,000 | $2,512,000,000 | $2,675,000,000 |
| Net Income Common Stockholders | $1,470,000,000 | $1,030,000,000 | $1,664,000,000 | $2,064,000,000 |
| Net Income | $1,470,000,000 | $1,030,000,000 | $1,664,000,000 | $2,064,000,000 |
| Net Income Including Noncontrolling Interests | $1,470,000,000 | $1,030,000,000 | $1,664,000,000 | $2,064,000,000 |
| Net Income Continuous Operations | $1,470,000,000 | $1,030,000,000 | $1,664,000,000 | $2,064,000,000 |
| Pretax Income | $1,999,000,000 | $1,415,000,000 | $2,190,000,000 | $2,637,000,000 |
| Special Income Charges | $-301,000,000 | $-767,000,000 | $19,000,000 | $-13,000,000 |
| Interest Income Non Operating | $51,000,000 | $53,000,000 | $108,000,000 | $0 |
| Operating Income | $2,715,000,000 | $2,629,000,000 | $2,493,000,000 | $2,688,000,000 |
| Gross Profit | $8,792,000,000 | $8,959,000,000 | $8,643,000,000 | $8,285,000,000 |
| Earnings From Equity Interest | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $0.76 | $0.54 | $0.90 | $1.09 |
| Basic EPS | $0.77 | $0.54 | $0.90 | $1.09 |
| Other | ||||
| Tax Effect Of Unusual Items | $-91,827,414 | $-228,551,237 | $-11,040,000 | $-11,718,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $3,333,000,000 | $3,308,000,000 | $3,221,000,000 | $3,335,000,000 |
| Total Unusual Items | $-347,000,000 | $-840,000,000 | $-46,000,000 | $-54,000,000 |
| Total Unusual Items Excluding Goodwill | $-347,000,000 | $-840,000,000 | $-46,000,000 | $-54,000,000 |
| Reconciled Depreciation | $557,000,000 | $622,000,000 | $627,000,000 | $644,000,000 |
| EBITDA (Bullshit earnings) | $2,986,000,000 | $2,468,000,000 | $3,175,000,000 | $3,281,000,000 |
| EBIT | $2,429,000,000 | $1,846,000,000 | $2,548,000,000 | $2,637,000,000 |
| Diluted Average Shares | $1,924,000,000 | $1,923,000,000 | $1,850,000,000 | $1,888,972,560 |
| Basic Average Shares | $1,917,000,000 | $1,915,000,000 | $1,846,000,000 | $1,888,972,560 |
| Diluted NI Availto Com Stockholders | $1,470,000,000 | $1,030,000,000 | $1,664,000,000 | $2,064,000,000 |
| Tax Provision | $529,000,000 | $385,000,000 | $526,000,000 | $573,000,000 |
| Gain On Sale Of Business | $17,000,000 | $0 | $0 | - |
| Other Special Charges | $5,000,000 | $4,000,000 | $26,000,000 | $-7,000,000 |
| Write Off | $23,000,000 | $22,000,000 | $0 | $12,000,000 |
| Impairment Of Capital Assets | $0 | $556,000,000 | - | $0 |
| Restructuring And Mergern Acquisition | $290,000,000 | $185,000,000 | $-45,000,000 | $0 |
| Gain On Sale Of Security | $-46,000,000 | $-73,000,000 | $-65,000,000 | $-41,000,000 |
| Other Taxes | $0 | $-21,000,000 | $0 | $0 |
| Selling General And Administration | $6,088,000,000 | $6,329,000,000 | $6,141,000,000 | $5,633,000,000 |
| Gain On Sale Of Ppe | - | $-6,000,000 | $9,000,000 | $-8,000,000 |
| Otherunder Preferred Stock Dividend | - | - | - | $632,000,000 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-7,438,000,000 | $-7,649,000,000 | $-7,679,000,000 | $932,000,000 |
| Total Assets | $27,076,000,000 | $25,601,000,000 | $27,851,000,000 | $27,316,000,000 |
| Total Non Current Assets | $21,379,000,000 | $20,076,000,000 | $21,713,000,000 | $21,439,000,000 |
| Other Non Current Assets | $727,000,000 | $726,000,000 | $623,000,000 | $434,000,000 |
| Non Current Deferred Assets | $237,000,000 | $184,000,000 | $158,000,000 | $147,000,000 |
| Non Current Deferred Taxes Assets | $237,000,000 | $184,000,000 | $158,000,000 | $147,000,000 |
| Goodwill And Other Intangible Assets | $18,203,000,000 | $17,317,000,000 | $18,890,000,000 | $19,038,000,000 |
| Other Intangible Assets | $8,694,000,000 | $8,474,000,000 | $9,619,000,000 | $9,853,000,000 |
| Current Assets | $5,697,000,000 | $5,525,000,000 | $6,138,000,000 | $5,877,000,000 |
| Other Current Assets | $155,000,000 | $205,000,000 | $265,000,000 | $123,000,000 |
| Inventory | $1,666,000,000 | $1,591,000,000 | $1,851,000,000 | $2,226,000,000 |
| Receivables | $2,814,000,000 | $2,659,000,000 | $2,640,000,000 | $2,297,000,000 |
| Other Receivables | $432,000,000 | $494,000,000 | $567,000,000 | $175,000,000 |
| Accounts Receivable | $2,382,000,000 | $2,165,000,000 | $2,073,000,000 | $2,122,000,000 |
| Allowance For Doubtful Accounts Receivable | $-26,000,000 | $-26,000,000 | $-25,000,000 | $-35,000,000 |
| Gross Accounts Receivable | $2,408,000,000 | $2,191,000,000 | $2,098,000,000 | $2,157,000,000 |
| Cash Cash Equivalents And Short Term Investments | $1,062,000,000 | $1,070,000,000 | $1,382,000,000 | $1,231,000,000 |
| Cash And Cash Equivalents | $1,062,000,000 | $1,070,000,000 | $1,382,000,000 | $1,231,000,000 |
| Debt | ||||
| Net Debt | $7,329,000,000 | $7,419,000,000 | $6,904,000,000 | $7,760,000,000 |
| Total Debt | $8,674,000,000 | $8,720,000,000 | $8,427,000,000 | $116,000,000 |
| Long Term Debt And Capital Lease Obligation | $7,178,000,000 | $7,132,000,000 | $7,784,000,000 | $81,000,000 |
| Long Term Debt | $6,938,000,000 | $6,937,000,000 | $7,687,000,000 | $8,930,000,000 |
| Current Debt And Capital Lease Obligation | $1,496,000,000 | $1,588,000,000 | $643,000,000 | $35,000,000 |
| Current Debt | $1,453,000,000 | $1,552,000,000 | $599,000,000 | - |
| Other Current Borrowings | $753,000,000 | $752,000,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $16,311,000,000 | $15,933,000,000 | $16,640,000,000 | $7,346,000,000 |
| Total Non Current Liabilities Net Minority Interest | $10,366,000,000 | $10,194,000,000 | $11,159,000,000 | $3,420,000,000 |
| Tradeand Other Payables Non Current | $354,000,000 | $328,000,000 | $329,000,000 | $584,000,000 |
| Non Current Deferred Liabilities | $2,354,000,000 | $2,261,000,000 | $2,621,000,000 | $2,479,000,000 |
| Non Current Deferred Taxes Liabilities | $2,354,000,000 | $2,261,000,000 | $2,621,000,000 | $2,479,000,000 |
| Current Liabilities | $5,945,000,000 | $5,739,000,000 | $5,481,000,000 | $3,926,000,000 |
| Payables And Accrued Expenses | $4,106,000,000 | $3,826,000,000 | $4,432,000,000 | $3,619,000,000 |
| Payables | $2,600,000,000 | $2,410,000,000 | $2,744,000,000 | $2,158,000,000 |
| Total Tax Payable | $127,000,000 | $156,000,000 | $255,000,000 | $329,000,000 |
| Income Tax Payable | $105,000,000 | $74,000,000 | $142,000,000 | $329,000,000 |
| Accounts Payable | $2,473,000,000 | $2,254,000,000 | $2,489,000,000 | $1,829,000,000 |
| Other Non Current Liabilities | - | $-1,000,000 | - | $646,000,000 |
| Minimum Pension Liabilities | - | - | - | $12,000,000 |
| Equity | ||||
| Common Stock Equity | $10,765,000,000 | $9,668,000,000 | $11,211,000,000 | $19,970,000,000 |
| Total Equity Gross Minority Interest | $10,765,000,000 | $9,668,000,000 | $11,211,000,000 | $19,970,000,000 |
| Stockholders Equity | $10,765,000,000 | $9,668,000,000 | $11,211,000,000 | $19,970,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-4,959,000,000 | $-6,146,000,000 | $-5,377,000,000 | $-5,455,000,000 |
| Other Equity Adjustments | $-4,959,000,000 | $-6,146,000,000 | $-5,377,000,000 | $-5,455,000,000 |
| Retained Earnings | $-204,000,000 | $-93,000,000 | $429,000,000 | $0 |
| Other Equity Interest | - | - | - | $25,425,000,000 |
| Other | ||||
| Treasury Shares Number | $20,386,722 | $11,208,444 | $350,000 | - |
| Ordinary Shares Number | $1,916,115,445 | $1,913,768,088 | $1,915,057,047 | $1,888,972,560 |
| Share Issued | $1,936,502,167 | $1,924,976,532 | $1,915,407,047 | $1,888,972,560 |
| Tangible Book Value | $-7,438,000,000 | $-7,649,000,000 | $-7,679,000,000 | $932,000,000 |
| Invested Capital | $19,156,000,000 | $18,157,000,000 | $19,497,000,000 | $19,970,000,000 |
| Working Capital | $-248,000,000 | $-214,000,000 | $657,000,000 | $1,951,000,000 |
| Capital Lease Obligations | $283,000,000 | $231,000,000 | $141,000,000 | $116,000,000 |
| Total Capitalization | $17,703,000,000 | $16,605,000,000 | $18,898,000,000 | $19,970,000,000 |
| Treasury Stock | $439,000,000 | $242,000,000 | $7,000,000 | $0 |
| Additional Paid In Capital | $16,348,000,000 | $16,130,000,000 | $16,147,000,000 | $0 |
| Capital Stock | $19,000,000 | $19,000,000 | $19,000,000 | $0 |
| Common Stock | $19,000,000 | $19,000,000 | $19,000,000 | $0 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Employee Benefits | $340,000,000 | $342,000,000 | $360,000,000 | $214,000,000 |
| Non Current Accrued Expenses | $140,000,000 | $132,000,000 | $65,000,000 | $62,000,000 |
| Long Term Capital Lease Obligation | $240,000,000 | $195,000,000 | $97,000,000 | $81,000,000 |
| Current Capital Lease Obligation | $43,000,000 | $36,000,000 | $44,000,000 | $35,000,000 |
| Commercial Paper | $700,000,000 | $800,000,000 | $599,000,000 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $343,000,000 | $325,000,000 | $406,000,000 | $272,000,000 |
| Current Accrued Expenses | $1,506,000,000 | $1,416,000,000 | $1,688,000,000 | $1,461,000,000 |
| Goodwill | $9,509,000,000 | $8,843,000,000 | $9,271,000,000 | $9,185,000,000 |
| Net PPE | $2,212,000,000 | $1,849,000,000 | $2,042,000,000 | $1,820,000,000 |
| Accumulated Depreciation | $-3,019,000,000 | $-2,701,000,000 | $-4,201,000,000 | $-3,880,000,000 |
| Gross PPE | $5,231,000,000 | $4,550,000,000 | $6,243,000,000 | $5,700,000,000 |
| Construction In Progress | $595,000,000 | $542,000,000 | $480,000,000 | $307,000,000 |
| Machinery Furniture Equipment | $2,723,000,000 | $2,352,000,000 | $3,938,000,000 | $3,609,000,000 |
| Buildings And Improvements | $1,853,000,000 | $1,599,000,000 | $1,749,000,000 | $1,709,000,000 |
| Land And Improvements | $60,000,000 | $57,000,000 | $76,000,000 | $75,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,288,000,000 | $1,216,000,000 | $1,432,000,000 | $1,752,000,000 |
| Work In Process | $103,000,000 | $101,000,000 | $115,000,000 | $123,000,000 |
| Raw Materials | $275,000,000 | $274,000,000 | $304,000,000 | $351,000,000 |
| Foreign Currency Translation Adjustments | - | - | - | $-5,474,000,000 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,722,000,000 | $1,335,000,000 | $2,699,000,000 | $2,150,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $2,197,000,000 | $1,769,000,000 | $3,168,000,000 | $2,525,000,000 |
| Cash Flow From Continuing Operating Activities | $2,197,000,000 | $1,769,000,000 | $3,168,000,000 | $2,525,000,000 |
| Operating Gains Losses | - | $72,000,000 | $7,000,000 | $-1,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-475,000,000 | $-434,000,000 | $-469,000,000 | $-375,000,000 |
| Investing Cash Flow | $-436,000,000 | $-425,000,000 | $-488,000,000 | $-390,000,000 |
| Cash Flow From Continuing Investing Activities | $-436,000,000 | $-425,000,000 | $-488,000,000 | $-390,000,000 |
| Net Other Investing Changes | $39,000,000 | $9,000,000 | $-19,000,000 | $-15,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-197,000,000 | $-235,000,000 | $-7,000,000 | $0 |
| Issuance Of Capital Stock | $0 | $0 | $4,241,000,000 | $0 |
| Financing Cash Flow | $-1,837,000,000 | $-1,565,000,000 | $-2,527,000,000 | $-1,583,000,000 |
| Cash Flow From Continuing Financing Activities | $-1,837,000,000 | $-1,565,000,000 | $-2,527,000,000 | $-1,583,000,000 |
| Net Other Financing Charges | $91,000,000 | $65,000,000 | $-467,000,000 | $-1,597,000,000 |
| Cash Dividends Paid | $-1,581,000,000 | $-1,552,000,000 | $-14,554,000,000 | $0 |
| Common Stock Dividend Paid | $-1,581,000,000 | $-1,552,000,000 | $-14,554,000,000 | $0 |
| Net Common Stock Issuance | $-197,000,000 | $-235,000,000 | $4,234,000,000 | $0 |
| Common Stock Issuance | $0 | $0 | $4,241,000,000 | $0 |
| Other | ||||
| Repayment Of Debt | $-896,000,000 | $0 | $0 | - |
| Issuance Of Debt | $746,000,000 | $157,000,000 | $8,260,000,000 | $14,000,000 |
| Interest Paid Supplemental Data | $440,000,000 | $439,000,000 | $224,000,000 | $0 |
| Income Tax Paid Supplemental Data | $595,000,000 | $810,000,000 | $699,000,000 | $316,000,000 |
| End Cash Position | $1,062,000,000 | $1,070,000,000 | $1,382,000,000 | $1,231,000,000 |
| Beginning Cash Position | $1,070,000,000 | $1,382,000,000 | $1,231,000,000 | $740,000,000 |
| Effect Of Exchange Rate Changes | $68,000,000 | $-91,000,000 | $-2,000,000 | $-61,000,000 |
| Changes In Cash | $-76,000,000 | $-221,000,000 | $153,000,000 | $552,000,000 |
| Common Stock Payments | $-197,000,000 | $-235,000,000 | $-7,000,000 | $0 |
| Net Issuance Payments Of Debt | $-150,000,000 | $157,000,000 | $8,260,000,000 | $14,000,000 |
| Net Short Term Debt Issuance | $-146,000,000 | $157,000,000 | $574,000,000 | $14,000,000 |
| Short Term Debt Payments | $-146,000,000 | - | - | - |
| Net Long Term Debt Issuance | $-4,000,000 | $0 | $7,686,000,000 | $0 |
| Long Term Debt Payments | $-750,000,000 | $0 | $0 | - |
| Long Term Debt Issuance | $746,000,000 | $0 | $7,686,000,000 | $0 |
| Net PPE Purchase And Sale | $-475,000,000 | $-434,000,000 | $-469,000,000 | $-375,000,000 |
| Purchase Of PPE | $-475,000,000 | $-434,000,000 | $-469,000,000 | $-375,000,000 |
| Change In Working Capital | $52,000,000 | $-571,000,000 | $797,000,000 | $-525,000,000 |
| Change In Other Working Capital | $43,000,000 | $27,000,000 | $-78,000,000 | $2,000,000 |
| Change In Other Current Liabilities | $-3,000,000 | $52,000,000 | $-212,000,000 | $48,000,000 |
| Change In Other Current Assets | $122,000,000 | $-17,000,000 | $-429,000,000 | $119,000,000 |
| Change In Payables And Accrued Expense | $14,000,000 | $-597,000,000 | $1,123,000,000 | $30,000,000 |
| Change In Payable | $14,000,000 | $-597,000,000 | $1,123,000,000 | $30,000,000 |
| Change In Account Payable | $41,000,000 | $-536,000,000 | $1,454,000,000 | $35,000,000 |
| Change In Tax Payable | $-27,000,000 | $-61,000,000 | $-331,000,000 | $-5,000,000 |
| Change In Income Tax Payable | $-27,000,000 | $-61,000,000 | $-331,000,000 | $-5,000,000 |
| Change In Inventory | $-12,000,000 | $182,000,000 | $349,000,000 | $-582,000,000 |
| Change In Receivables | $-112,000,000 | $-218,000,000 | $44,000,000 | $-142,000,000 |
| Changes In Account Receivables | $-112,000,000 | $-218,000,000 | $44,000,000 | $-142,000,000 |
| Other Non Cash Items | $67,000,000 | $69,000,000 | $-1,000,000 | $14,000,000 |
| Stock Based Compensation | $136,000,000 | $254,000,000 | $188,000,000 | $137,000,000 |
| Asset Impairment Charge | $23,000,000 | $578,000,000 | $0 | $12,000,000 |
| Deferred Tax | $-108,000,000 | $-285,000,000 | $-114,000,000 | $180,000,000 |
| Deferred Income Tax | $-108,000,000 | $-285,000,000 | $-114,000,000 | $180,000,000 |
| Depreciation Amortization Depletion | $557,000,000 | $622,000,000 | $627,000,000 | $644,000,000 |
| Depreciation And Amortization | $557,000,000 | $622,000,000 | $627,000,000 | $644,000,000 |
| Amortization Cash Flow | $257,000,000 | $269,000,000 | $322,000,000 | $348,000,000 |
| Amortization Of Intangibles | $257,000,000 | $269,000,000 | $322,000,000 | $348,000,000 |
| Depreciation | $300,000,000 | $353,000,000 | $305,000,000 | $296,000,000 |
| Net Income From Continuing Operations | $1,470,000,000 | $1,030,000,000 | $1,664,000,000 | $2,064,000,000 |
| Short Term Debt Issuance | - | $157,000,000 | $574,000,000 | $14,000,000 |
| Gain Loss On Investment Securities | - | $72,000,000 | $7,000,000 | $-1,000,000 |
| Change In Accrued Expense | - | - | $1,064,000,000 | $-17,000,000 |
| Net Investment Purchase And Sale | - | - | - | $-5,000,000 |
| Purchase Of Investment | - | - | - | $-5,000,000 |
| Net Business Purchase And Sale | - | - | - | $-10,000,000 |
| Sale Of Business | - | - | - | $8,000,000 |
| Purchase Of Business | - | - | - | $-18,000,000 |
| Provisionand Write Offof Assets | - | - | - | $9,000,000 |
| Earnings Losses From Equity Investments | - | - | - | - |
Fetched: 2026-06-17